The names of the first 10 Medicare drugs whose prices the federal government will negotiate directly with manufacturers were released Aug. 29. Popular but pricey blood thinners, diabetes medications, cancer treatments make historic list.
The AARP Public Policy Institute has been tracking manufacturer price changes for widely used prescription drugs since 2004. They have reported their findings in a continuing Rx Watchdog report series.
The following article was submitted by guest commentator West Virginia Treasurer Riley Moore. It focuses on West Virginia's SMART529 Education Savings Program.